These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 2359688

  • 21. Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial.
    Akhondzadeh S, Tavakolian R, Davari-Ashtiani R, Arabgol F, Amini H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):841-5. PubMed ID: 12921918
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML, American Academy of Pediatrics Committee on Quality Improvement, American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder.
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [Abstract] [Full Text] [Related]

  • 24. Overcoming the barriers to effective treatment for attention-deficit/hyperactivity disorder: a neuro-educational approach.
    Monastra VJ.
    Int J Psychophysiol; 2005 Oct; 58(1):71-80. PubMed ID: 15927296
    [Abstract] [Full Text] [Related]

  • 25. Pharmacotherapy with atomoxetine for US children and adolescents.
    Bhatara VS, Aparasu RR.
    Ann Clin Psychiatry; 2007 Oct; 19(3):175-80. PubMed ID: 17729019
    [Abstract] [Full Text] [Related]

  • 26. Stimulant and psychosocial treatment of ADHD in Latino/Hispanic children.
    Bauermeister JJ, Canino G, Bravo M, Ramírez R, Jensen PS, Chavez L, Martínez-Taboas A, Ribera J, Alegría M, García P.
    J Am Acad Child Adolesc Psychiatry; 2003 Jul; 42(7):851-5. PubMed ID: 12819445
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Use of medication by young people with attention-deficit/hyperactivity disorder.
    Sawyer MG, Rey JM, Graetz BW, Clark JJ, Baghurst PA.
    Med J Aust; 2002 Jul 01; 177(1):21-5. PubMed ID: 12088474
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Improving recognition and management of ADHD.
    Forbes F.
    Practitioner; 2010 Apr 01; 254(1728):34-8, 3. PubMed ID: 20486482
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The use of health care services and psychotropic medication in a community sample of 9-year-old schoolchildren with ADHD.
    Tremmery S, Buitelaar JK, Steyaert J, Molenberghs G, Feron FJ, Kalff AC, Hurks PP, Hendriksen JG, Vles JS, Jolles J.
    Eur Child Adolesc Psychiatry; 2007 Aug 01; 16(5):327-36. PubMed ID: 17636356
    [Abstract] [Full Text] [Related]

  • 40. Primary care providers often first line of ADHD treatment.
    Mitchell L.
    J Okla State Med Assoc; 2009 Nov 01; 102(11):362. PubMed ID: 20034251
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.